Tranquis Therapeutics Strengthens Leadership Team with Additions of Janet Hurt, MPH, as SVP of Clinical Evidence Generation and Faisal Shawwa, MBA, as SVP of Finance

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Tranquis Therapeutics, a private immuno-neurology company developing innovative medicines with the potential to revolutionize the management of neurodegenerative and aging-related diseases by reprogramming dysfunctional myeloid immune cells, today announced it has strengthened its management team with the addition of Faisal Shawwa, MBA, as Senior Vice President of...

Click to view original post